Repurposing chemotherapy-induced peripheral neuropathy grading.

ABSTRACT:

Background and purpose

Chemotherapy-induced peripheral neuropathy (CIPN) is perceived differently by patients and physicians, complicating its assessment. Current recommendations advocate combining clinical and patient-reported outcomes measures, but this approach can be challenging in patient care. This multicenter European study aims to bridge the gap between patients' perceptions and neurological impairments by aligning both perspectives to improve treatment decision-making.

Methods

Data were pooled from two prospective studies of subjects (n = 372) with established CIPN. Patient and physician views regarding CIPN were assessed using the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE), Total Neuropathy Scale-clinical version (TNSc) ite

SUBMITTER: Velasco R 

PROVIDER: S-EPMC11554987 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature